Isoformic PD-1-mediated immunosuppression underlies resistance to PD-1 blockade in hepatocellular carcinoma patients.
Tan Z, Chiu MS, Yang X, Yue M, Cheung TT, Zhou D, Wang Y, Chan AW, Yan CW, Kwan KY, Wong YC, Li X, Zhou J, To KF, Zhu J, Lo CM, Cheng AS, Chan SL, Liu L, Song YQ, Man K, Chen Z.
Tan Z, et al. Among authors: li x.
Gut. 2023 Aug;72(8):1568-1580. doi: 10.1136/gutjnl-2022-327133. Epub 2022 Nov 30.
Gut. 2023.
PMID: 36450387